Journals By Industry - Drug Delivery Systems

CGEN-15001, CGEN-15021 and CGEN-15091 are predicted B7/CD28-like proteins discovered using the company's Protein Family Members Discovery Platform. The company reported that in the collagen induced arthritis model of RA, treatments with either CGEN-15001...

BALERNA, Switzerland -- APR Applied Pharma Research s.a. ("APR"), Labtec GmbH ("Labtec") and Norgine BV ("Norgine") announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm[TM] Ondansetron...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/1864b5/key_companies_neu) has announced the addition of the "Key Companies: Neuropathic Pain - In-house to in-license as Big Pharma cuts down on early-stage research" report to their offering. Pfizer...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/dc66aa/osteoporosis_thera) has announced the addition of GlobalData 's new report "Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. The Osteoporosis Therapeutics Market is...

WALTHAM, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, January...

BRIDGEWATER, N.J. -- NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced that, as previously disclosed, it is continuing to explore various...

MedPro EVP Garyen Denning to Speak at Drug Delivery Partnerships Conference LEXINGTON, Ky. -- MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood...

Developing therapeutics using novel biology to selectively activate genes CAMBRIDGE, Mass. -- RaNA Therapeutics, Inc. today announced it has completed a $20.7 million round of financing co-led by Atlas Venture, SR One, and...

Investment to Support Commercialization of its Navigator[TM] Delivery System ALPHARETTA, Ga. -- Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee...

EMERYVILLE, Calif. -- KineMed, Inc. (www.kinemed.com) announced today that co-founders Marc Hellerstein M.D., Ph.D., Chairman of the Scientific Advisory Board of KineMed and David Fineman, KineMed's CEO, will present at the 2012 Personalized...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/147783/successful_strateg) has announced the addition of the "Successful Strategies for Pharmaceutical Reformulation" report to their offering. This report assesses the various approaches to reformulation in the protection of...

Convertible notes extended to February 28, 2012 PORTLAND, Ore. -- Bioject Medical Technologies Inc. (OCTBB: BJCT), a leading developer of needle-free drug delivery systems, today announced that it has retained the services of...

EWING, N.J. -- Antares Pharma, Inc. (NYSE Amex: AIS) today announced that it has licensed exclusively its Oxybutynin Gel 3% to Daewoong Pharmaceuticals Co. Ltd.,for marketing in South Korea. Antares will receive undisclosed...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/eb5d32/product_profiles) has announced the addition of the "Product Profiles: Moderate-To-Severe Acute Pain - Intensifying competition in breakthrough cancer pain market" report to their offering. Since the beginning of...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing oncology and CNS therapeutics, today provided guidance on its key pipeline, scientific and business goals for 2012. "Rexahn...

BERLIN -- JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), IUCT and LEITAT (Barcelona, Spain) announced today their collaboration on the joint development of an enhanced anticancer therapy...

New breathable energy product now available for purchase in retail outlets in Boston and New York CAMBRIDGE, Mass. -- Breathable Foods announces the official launch of AeroShot Pure Energy in Boston and New...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/a89f59/handbook_of_harnes) has announced the addition of the "Handbook of Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity and Applications" book to their offering. Nanomedicine has emerged as a novel field...